134 related articles for article (PubMed ID: 8700228)
21. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
22. Two candidate downstream target genes for E2A-HLF.
Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
[TBL] [Abstract][Full Text] [Related]
23. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
24. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
25. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
[TBL] [Abstract][Full Text] [Related]
26. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
[TBL] [Abstract][Full Text] [Related]
27. Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.
Honda H; Inaba T; Suzuki T; Oda H; Ebihara Y; Tsuiji K; Nakahata T; Ishikawa T; Yazaki Y; Hirai H
Blood; 1999 May; 93(9):2780-90. PubMed ID: 10216071
[TBL] [Abstract][Full Text] [Related]
28. E2A-HLF chimeric transcription factors in pro-B cell acute lymphoblastic leukemia.
Look AT
Curr Top Microbiol Immunol; 1997; 220():45-53. PubMed ID: 9103674
[No Abstract] [Full Text] [Related]
29. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
Mikkers H; Allen J; Berns A
Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
Newcombe K; Glassco T; Mueller C
Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
[TBL] [Abstract][Full Text] [Related]
32. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
33. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
[TBL] [Abstract][Full Text] [Related]
34. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
[TBL] [Abstract][Full Text] [Related]
35. Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.
Smith KS; Rhee JW; Cleary ML
Mol Cell Biol; 2002 Nov; 22(21):7678-87. PubMed ID: 12370314
[TBL] [Abstract][Full Text] [Related]
36. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
37. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
38. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
39. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
Smith KS; Rhee JW; Naumovski L; Cleary ML
Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
